Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,368 | -127,410 | -95,478 | -70,303 | -38,169 |
| Depreciation Amortization | -484 | -758 | -157 | 5 | N/A |
| Accounts payable and accrued liabilities | 2,328 | 361 | 60 | 4,938 | 2,677 |
| Other Working Capital | 9,340 | -8,197 | 2,341 | 3,406 | 1,581 |
| Other Operating Activity | 5,103 | 41,315 | 32,194 | 23,038 | 15,154 |
| Operating Cash Flow | $-24,081 | $-94,689 | $-61,040 | $-38,916 | $-18,757 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 14,384 | -148,651 | N/A | N/A |
| PPE Investments | N/A | -196 | -193 | -136 | N/A |
| Purchase Of Investment | -73,898 | -261,194 | N/A | N/A | N/A |
| Sale Of Investment | 65,428 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-8,470 | $-247,006 | $-148,844 | $-136 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 360,228 | N/A | N/A | N/A |
| Common Stock Issued | 45 | 384 | 190,452 | N/A | N/A |
| Other Financing Activity | -840 | 156 | 156 | 190,608 | -700 |
| Financing Cash Flow | $-795 | $360,768 | $190,608 | $190,608 | $-700 |
| Exchange Rate Effect | -7 | -21 | N/A | N/A | N/A |
| Beginning Cash Position | 88,438 | 69,386 | 69,386 | 69,386 | 69,386 |
| End Cash Position | 55,085 | 88,438 | 50,106 | 220,942 | 49,929 |
| Net Cash Flow | $-33,353 | $19,052 | $-19,280 | $151,556 | $-19,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,081 | -94,689 | -61,040 | -38,916 | -18,757 |
| Capital Expenditure | N/A | -196 | -193 | -136 | N/A |
| Free Cash Flow | -24,081 | -94,885 | -61,233 | -39,052 | -18,757 |